Phase 1 Trial of Ipilimumab and GVAX in Patients With Metastatic Castration-resistant Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01510288
Recruitment Status : Terminated (The study was terminated because Cell Genesys stopped all activities for GVAX.)
First Posted : January 16, 2012
Last Update Posted : January 16, 2012
Cell Genesys
Information provided by (Responsible Party):
A.J.M. van den Eertwegh, VU University Medical Center